Literature DB >> 18929681

Progesterone and progestins: neuroprotection and myelin repair.

Michael Schumacher1, Regine Sitruk-Ware, Alejandro F De Nicola.   

Abstract

Progesterone, known for its role in pregnancy, also exerts marked effects on the nervous system. Its neuroprotective and promyelinating actions, now well documented by experimental studies, make it a particularly promising therapeutic agent for neuroinjury and neurodegenerative diseases. This concept has recently been translated into clinical practice, though there is need for more experimental studies and investigations on the mechanisms of the actions of progesterone. However, it is important to be aware that most of the experimental research concerns the effects of physiological progesterone. Although progesterone represents an interesting therapeutic option, the recognition of its beneficial effects on the nervous system also suggests novel therapeutic benefits for some synthetic progestins derived from progesterone, currently used for contraception or in postmenopausal hormone replacement therapies (HRTs).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18929681     DOI: 10.1016/j.coph.2008.10.002

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  24 in total

Review 1.  Activation of progestin receptors in female reproductive behavior: Interactions with neurotransmitters.

Authors:  Shaila Mani; Wendy Portillo
Journal:  Front Neuroendocrinol       Date:  2010-01-29       Impact factor: 8.606

Review 2.  Protective actions of sex steroid hormones in Alzheimer's disease.

Authors:  Christian J Pike; Jenna C Carroll; Emily R Rosario; Anna M Barron
Journal:  Front Neuroendocrinol       Date:  2009-05-07       Impact factor: 8.606

3.  Multimodal analysis in acute and chronic experimental autoimmune encephalomyelitis.

Authors:  Silvia Giatti; Mariaserena Boraso; Federico Abbiati; Elisa Ballarini; Donato Calabrese; Maria Santos-Galindo; Roberta Rigolio; Marzia Pesaresi; Donatella Caruso; Barbara Viviani; Guido Cavaletti; Luis Miguel Garcia-Segura; Roberto Cosimo Melcangi
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-30       Impact factor: 4.147

4.  Modifications of neuroactive steroid levels in an experimental model of nigrostriatal degeneration: potential relevance to the pathophysiology of Parkinson's disease.

Authors:  Roberto Cosimo Melcangi; Donatella Caruso; Giovanna Levandis; Federico Abbiati; Marie-Therese Armentero; Fabio Blandini
Journal:  J Mol Neurosci       Date:  2011-06-14       Impact factor: 3.444

Review 5.  Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.

Authors:  Frank Z Stanczyk; Janet P Hapgood; Sharon Winer; Daniel R Mishell
Journal:  Endocr Rev       Date:  2012-12-13       Impact factor: 19.871

6.  Estrogen protection against mitochondrial toxin-induced cell death in hippocampal neurons: antagonism by progesterone.

Authors:  Jia Yao; Shuhua Chen; Enrique Cadenas; Roberta Diaz Brinton
Journal:  Brain Res       Date:  2010-12-04       Impact factor: 3.252

7.  Progesterone and allopregnanolone improves stroke outcome in male mice via distinct mechanisms but neither promotes neurogenesis.

Authors:  Rona J Lee; Joon Kyung Kim; Diana Chao; Lisa Kuo; Adheip Mally; Megan E McClean; Heather E Pemberton; Andrew R Wilmington; Jennifer Wong; Sean P Murphy
Journal:  J Neurochem       Date:  2014-12-02       Impact factor: 5.372

8.  Progesterone Changes VEGF and BDNF Expression and Promotes Neurogenesis After Ischemic Stroke.

Authors:  Chao Jiang; Fangfang Zuo; Yuejuan Wang; Hong Lu; Qingwu Yang; Jian Wang
Journal:  Mol Neurobiol       Date:  2016-01-08       Impact factor: 5.590

9.  Differential effects of synthetic progestagens on neuron survival and estrogen neuroprotection in cultured neurons.

Authors:  Anusha Jayaraman; Christian J Pike
Journal:  Mol Cell Endocrinol       Date:  2014-01-11       Impact factor: 4.102

10.  Use of Hormone Therapy in Postmenopausal Women with Alzheimer's Disease: A Systematic Review.

Authors:  Camila A E F Cardinali; Yandara A Martins; Andréa S Torrão
Journal:  Drugs Aging       Date:  2021-08-03       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.